ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy

J Cataract Refract Surg. 2003 Sep;29(9):1800-10. doi: 10.1016/s0886-3350(03)00560-1.

Abstract

Many antiglaucoma eyedrops are reported to cause cystoid macular edema (CME) in aphakia and pseudophakia. We review 4 clinical and laboratory studies that compare the incidence of CME in early postoperative pseudophakia in eyes that received preserved latanoprost and timolol, nonpreserved timolol, and the preserved and nonpreserved vehicle for these drugs and looked at the morphological damage to cells and the changes in the indicators of cytokine and prostaglandin (PG) synthesis caused by latanoprost and timolol and the preservative benzalkonium chloride. Based on the findings of these studies, which indicate that the preservative causes increased synthesis of PGs and other substances and intensified postoperative inflammation, the term pseudophakic preservative maculopathy is proposed for CME caused by antiglaucoma eyedrops.

Publication types

  • Comparative Study
  • Lecture

MeSH terms

  • Aqueous Humor / drug effects
  • Cataract Extraction / adverse effects
  • Humans
  • Incidence
  • Inflammation / etiology
  • Intraocular Pressure / drug effects
  • Latanoprost
  • Macular Edema / chemically induced
  • Macular Edema / epidemiology
  • Macular Edema / etiology*
  • Ophthalmic Solutions
  • Preservatives, Pharmaceutical / adverse effects*
  • Prostaglandins F, Synthetic / administration & dosage
  • Pseudophakia / complications*
  • Timolol / administration & dosage

Substances

  • Ophthalmic Solutions
  • Preservatives, Pharmaceutical
  • Prostaglandins F, Synthetic
  • Latanoprost
  • Timolol